|
|
|
|
| | |
| | |
|
|
|
|
| | |
| |
 |
|
|
 |
|
| | |
名誉教授・
客員教授 |
： |
樋口 安典 |
| 研究テーマ |
： |
オステオポンチン(OPN)の機能解析 |
|
|
|
| 研究内容 | ： |
OPNは骨芽細胞に強く発現する分泌燐蛋白である。その機能は多彩で、機能と活性部位の関係をin vitroで解析している。特に骨粗鬆症との関連で。 |
|
|
|
| |  | | | | 1) | Nakamura,
K., Tsukamoto, Y., Hijiya, N., Higuchi, Y., Yano, S., Yokoyama, S.,
Kumamoto T., Moriyama M.: Induction of GNE in myofibers after muscle
injury. Pathobiol. 77: 191-199, 2010 |
| | | | | 2) | Matsuno,
O., Ono, E., Ueno, T.,Takenaka, R., Nishitake, T., Hiroshige,
S.,Miyazaki, E., Kumamoto, T.,Higuchi Y.: Increased serum ADAM8
concentration in patientswith drug-induced eosinophilic
pneumonia-ADAM8expression depends on the allergen route of entry. Resp.
Med. 104: 34-39, 2010 |  | | | | | 3) | Eshima,
N., Iwata, O., Iwata, S.,Tabata, M., Higuchi, Y.,Matsuishi,
T.,Karukaya, S.: Age and gender specific prevalence of HTLV-1. J. Clin.
Virol. 45: 135-138, 2009 | | | | | | 4) | Ishii,
S., Chang, H.-H., Yoshioka, H., Shimada, T.,Mannen, K.,Higuchi, Y.,
Taguchi, A., Fan, J.-Q.: Preclinical efficacy and safety of
1-deoxygalactonojirimycin in mice for Fabry disease. J. Pharamacol.
Exp. Ther. 328: 723-731, 2009 | | | | | | 5) | Matsuno, O., Kumamoto, T., Higuchi, Y.: ADAM8 in Allergy. Inflamma. AllergyDrug Targets 7: 108-112, 2008 |
| | | | | 6) | Matsuno,
O., Miyazaki, E., Nureki, S., Ueno, T., Ando, M., Ito, K., Kumamoto,
T., Higuchi, Y.: Elevated soluble ADAM8 in BALF in patients with
eosinophilic pneumonia. Int. Arch. Aller. Immunol. 142(4):285-290, 2007 |
|
|
|
|
| | |
|
| | |
|
| | |
| | | |
| | | |
 | | |
|
|
|
|
| | |
|
